Article

Alison Morris on the Future of Screening for Distress

Author(s):

Alison Morris

Alison Morris, Hematology/Oncology Nurse Practitioner, Stanford Health Care, discusses her hopes for the future of screening for emotional and physical distress.

Alison Morris, Hematology/Oncology Nurse Practitioner, Stanford Health Care, discusses her hopes for the future of screening for emotional and physical distress.

Learn more about a study looking at emotional and physical distress.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients
A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients
Image of a woman wearing a headband and glasses
An Expert Breaks Down Lymphedema Following Cancer Care
Image of man.
Early Detection and Screening is Key for Esophageal Cancer
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Image of doctor.
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
CURE spoke with Andy Guinigundo to discuss the role that biomarkers play for patients with breast cancer.
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment
Image of doctor.
Machine Learning Improves Transplant Risk Assessment in Myelofibrosis
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
Breaking Down Kidney Cancer Treatment Advancements and Providing Hope
Related Content
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Image of Dr. Fakih.
February 27th 2025

ctDNA Alone ‘Not Sufficient’ When Monitoring Patients With Colorectal Cancer

Dr. Marwan Fakih
The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients with colorectal cancer.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.